Cargando…
Drug Therapy for Hypertrophic Cardiomypathy: Physiology and Practice
HCM is the most common inherited heart condition occurring in 1:500 individuals in the general population. Left ventricular outflow obstruction at rest or after provocation occurs in 2/3 of HCM patients and is a frequent cause of limiting symptoms. Pharmacologic therapy is the first-line treatment f...
Autor principal: | V. Sherrid, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807719/ https://www.ncbi.nlm.nih.gov/pubmed/26818487 http://dx.doi.org/10.2174/1573403X1201160126125403 |
Ejemplares similares
-
Indications for Surgery in Obstructive Hypertrophic Cardiomyopathy
por: Sherrid, Mark V.
Publicado: (2020) -
Apical Ballooning and Cardiogenic Shock in Obstructive Hypertrophic Cardiomyopathy
por: Sherrid, Mark V., et al.
Publicado: (2018) -
COVID-19 in Adults With Hypertrophic Cardiomyopathy
por: Arabadjian, Milla E., et al.
Publicado: (2021) -
Disease Expression and Outcomes in Black and White Adults With Hypertrophic Cardiomyopathy
por: Arabadjian, Milla E., et al.
Publicado: (2021) -
On-pump intracardiac echocardiography during septal myectomy for hypertrophic cardiomyopathy
por: Williams, David M., et al.
Publicado: (2020)